Establishment obligations and the 30-working-day closure notice
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Obtaining the licence is only the starting point. Article 11 of Acuerdo No. 0631-ARSA-2023 imposes 6 continuing obligations on the establishment (or the person responsible for it): maintain facilities and professionals with a technical-scientific background proportionate to the nature of the products and the activities carried out; supervise the circulation of devices and keep an electronic distribution record to guarantee traceability; maintain accurate inventory and rotate stock in a manner that does not impair quality, safety and performance; provide information on device stocks when required; maintain the technical equipment needed to secure the storage and transport conditions fixed by the manufacturer, especially for products requiring special preservation conditions; and delimit the establishment’s activities according to the scope ARSA has defined for each class of authorisation. Two further provisions are hard constraints: Article 15 prohibits operating without a valid licence or carrying out activities and services not expressly approved on the licence; and Article 16 requires the owner or legal representative of the establishment to notify ARSA within 30 working days of a temporary or permanent closure, with an ARSA inspection before reopening and a prior modification application where the activities stated on the licence have changed.
2. Legal basis
The obligations of the licence holder rest on a cluster of articles of Acuerdo No. 0631-ARSA-2023 covering premises duties, prohibitions, closure, display, the technical director, suspension and sampling costs. The table below consolidates them.
| Level | Instrument | Provision | Key point |
| Regulation | Acuerdo No. 0631-ARSA-2023 | Article 11 | 6 establishment obligations: facilities and personnel, electronic distribution records, inventory and rotation, information provision, storage and transport equipment, delimitation of activities |
| Regulation | Acuerdo No. 0631-ARSA-2023 | Article 15 | Prohibition of operating without a valid licence and of activities or services not expressly approved |
| Regulation | Acuerdo No. 0631-ARSA-2023 | Article 16 | Closure must be notified within 30 working days; inspection before reopening; changes of activities require a prior modification |
| Regulation | Acuerdo No. 0631-ARSA-2023 | Article 9 | The licence must be displayed prominently and a technical director appointed |
| Regulation | Acuerdo No. 0631-ARSA-2023 | Article 10 | 8 functions of the technical director |
| Regulation | Acuerdo No. 0631-ARSA-2023 | Article 13 | Issued licences may be suspended or cancelled on application or ex officio |
| Regulation | Acuerdo No. 0631-ARSA-2023 | Articles 80–82 | Sampling and testing cost allocation (linked to establishment obligations) |
3. Expert insights
Insight 1: the electronic distribution record is where traceability lands. Article 11, item 2 does not stop at keeping a ledger; it expressly requires an electronic record of distribution. This echoes the definition of Trazabilidad in Article 3, Section II, the ability to identify the origin, flow and location of a specific unit or batch or serial number, and it determines how fast a company can respond in vigilance and recall scenarios.
Insight 2: stock rotation is written as a quality obligation. Article 11, item 3 requires accurate inventory and provides that rotation must take place under conditions that do not impair the quality, safety and performance of the devices. For shelf-life-sensitive products, including the categories subject to the Article 74 requirement of at least 9 months of remaining shelf life at import, rotation rules belong in the SOPs, not merely in financial first-in-first-out practice.
Insight 3: closure is a notification duty, not an internal decision. Article 16 brings both temporary and permanent closure within the 30-working-day notification scope and requires an ARSA inspection before reopening. The practical cost is that after notifying closure, resuming operations requires another scheduled inspection, and that waiting time is pure cost.
Insight 4: the scope of activities is the core boundary of the licence. Article 11, item 6 requires the establishment’s activities to be delimited according to the scope ARSA has defined for each class of authorisation, forming a pair with the prohibition in Article 15: only what the licence states may be done, and anything beyond it is a violation. This explains why the fee tables of Acuerdo 003-2021 price the six activities of Acondicionar, Almacenar, Importar, Distribuir, Comercializar and Fabricar separately. The activity is the smallest unit of the licence.
Insight 5: obligations cascade down to the technical director. Article 11 opens with the titular or the authorised person responsible for the premises, while Article 9 requires the licence to be displayed prominently and a technical director appointed, and Article 10 lists that director’s 8 functions. Establishment obligations must therefore land on specific positions within the organisation, not rest formally on the legal entity alone.
4. Practical recommendations
- Break the 6 obligations into SOPs with named owners: facilities and personnel to HR and quality, electronic distribution records and stock rotation to warehousing, storage and transport conditions to equipment, and scope of activities to compliance.
- Make the distribution record electronic and searchable by batch or serial number, with fields covering at least product name, registration number, batch or serial number, quantity, consignee and date, to satisfy the definition of Trazabilidad.
- Establish rotation and near-expiry alert rules for shelf-life-sensitive categories, aligned with the 9-month remaining shelf life requirement of Article 74.
- Put closure, relocation, reconstruction and reopening into one change-trigger table: notify closure within 30 working days, apply for any modification first, and then await inspection before reopening.
- Review once a year whether the activities stated on the licence match the actual business; where an addition is needed, use the activity-expansion change of Article 20, item 7 with the additional fee under Article 22.
- When the technical director changes, process the change under Article 20, item 2 in parallel and ensure the 8 functions of Article 10 are handed over with written records.
5. Verification checklist
- □ The 6 establishment obligations have been broken into SOPs with responsible positions assigned
- □ The electronic distribution record system is live and searchable by batch or serial number
- □ Rotation and near-expiry alert rules are written into the warehouse operating documents
- □ The list of storage and transport equipment has been checked item by item against the conditions fixed by the manufacturer
- □ The annual review of licensed activities versus actual business scope has been completed
- □ Trigger and notification procedures for closure, relocation, reconstruction and reopening are in the management system (30 working days)
- □ The technical director is in post and displayed on the licence, with a valid professional card
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Honduran market. Our team manages Secretariat of Health (SESAL) registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Regulatory information verified as of October 29, 2026.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us